Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma

Phase 2

Completed

Conditions: Pancreatic Adenocarcinoma

Interventions: Drug: Gemcitabine
Drug: Nab-paclitaxel
Drug: Durvalumab
Drug: Tremelimumab

First Posted Date: 2016-08-25

Last Posted Date: 2025-03-24

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 180

Registration Number: NCT02879318

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada

and more 24 locations

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: Tremelimumab
Drug: Durvalumab
Other: Best Supportive Care

First Posted Date: 2016-08-17

Last Posted Date: 2023-12-08

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 180

Registration Number: NCT02870920

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
The Moncton Hospital, Moncton, New Brunswick, Canada

and more 22 locations

The Efficacy, Safety, and Tolerability of Probiotics on the Mood and Cognition of Depressed Patients

Phase 3

Completed

Conditions: Major Depressive Disorder
Depressive Symptoms
Depression

Interventions: Dietary Supplement: Probio'Stick

First Posted Date: 2016-07-20

Last Posted Date: 2019-06-14

Lead Sponsor: Queen's University

Target Recruit Count: 10

Registration Number: NCT02838043

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada
🇨🇦
Providence Care - Mental Health Services, Kingston, Ontario, Canada

Duration of Anti-PD-1 Therapy in Metastatic Melanoma

Phase 3

Recruiting

Conditions: Unresectable/Metastatic Melanoma

Interventions: Drug: Continuous PD-1 inhibitor therapy
Drug: Intermittent PD-1 inhibitor therapy

First Posted Date: 2016-07-01

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 614

Registration Number: NCT02821013

Locations: 🇦🇺
Mildura Base Public Hospital, Victoria, Mildura, Australia
🇦🇺
Coffs Habour Health Campus - NCCI, Coffs Harbour, New South Wales, Australia
🇦🇺
Riverina Cancer Care Centre Wagga Wagga, Wagga Wagga, New South Wales, Australia

and more 28 locations

The Effects of ECT and/or iTBS on Olfaction and Cognition in Patients With Depression

Completed

Conditions: Depression

Interventions: Device: Cognitive Function Imaging and Battery
Device: Sniffin Sticks
Other: Cognitive Batteries

First Posted Date: 2016-06-17

Last Posted Date: 2017-09-06

Lead Sponsor: Queen's University

Target Recruit Count: 30

Registration Number: NCT02804347

Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Drug: Durvalumab
Drug: Tremelimumab

First Posted Date: 2016-06-02

Last Posted Date: 2025-05-15

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 52

Registration Number: NCT02788773

Locations: 🇨🇦
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada

and more 8 locations

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Phase 2

Completed

Conditions: Mesothelioma

Interventions: Drug: Cisplatin
Drug: Pemetrexed
Drug: Pembrolizumab

First Posted Date: 2016-05-26

Last Posted Date: 2024-12-10

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 520

Registration Number: NCT02784171

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada

and more 53 locations

Response to Pembrolizumab in Metastatic Melanoma: Computed Tomography Texture Analysis as a Predictive Biomarker

Phase 2

Terminated

Conditions: Metastatic Melanoma

Interventions: Drug: Pembrolizumab
Procedure: CT Scan

First Posted Date: 2016-04-15

Last Posted Date: 2023-08-25

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 9

Registration Number: NCT02740920

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦
London Regional Cancer Program, London, Ontario, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 2 locations

Magnesium-Based Trigger Point Injections for Relief of Chronic Myofascial Pelvic Pain

Phase 3

Terminated

Conditions: Pelvic Pain

Interventions: Procedure: Magnesium-Based Injection Formulation
Procedure: Lidocaine-Only Injection Formulation
Drug: lidocaine
Drug: magnesium sulfate, bicarbonate, dextrose.

First Posted Date: 2016-04-05

Last Posted Date: 2023-03-31

Lead Sponsor: Queen's University

Target Recruit Count: 38

Registration Number: NCT02728037

Locations: 🇨🇦
Department of Obstetrics & Gynecology, Queen's Unviersity, Kingston, Ontario, Canada

A Phase I Study of CX5461

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: CX5461

First Posted Date: 2016-03-25

Last Posted Date: 2023-08-04

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 41

Registration Number: NCT02719977

Locations: 🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy